Belite Bio, Inc Shareholders' Equity
Belite Bio, Inc (BLTE) had Shareholders' Equity of $770.49 million as of 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-03-31
- 2025-12-31: Stockholders' Equity Attributable to Parent $770.49M.
- 2024-12-31: Stockholders' Equity Attributable to Parent $145.82M.
- 2023-12-31: Stockholders' Equity Attributable to Parent $90.43M.
- 2022-12-31: Stockholders' Equity Attributable to Parent $41.50M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2025-12-31 | $770.49M 20-F · filed 2026-03-31 |
| 2024-12-31 | $145.82M 20-F · filed 2026-03-31 |
| 2023-12-31 | $90.43M 20-F · filed 2026-03-31 |
| 2022-12-31 | $41.50M 20-F · filed 2026-03-31 |
| 2021-12-31 | -$15.09M 20-F · filed 2025-03-17 |
| 2020-12-31 | -$7.04M 20-F · filed 2024-03-12 |
| 2019-12-31 | -$3.74M 20-F · filed 2023-03-31 |